COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,843 Articles (22,553 medRxiv, 8,290 bioRxiv)

Most recent first Previous |  Page 266: Articles 2651-2660  | Next

Virological characteristics of the SARS-CoV-2 Omicron HK.3 variant harboring the "FLip" substitution
Kosugi, Y., Plianchaisuk, A., Putri, O., Uriu, K., Kaku, Y., Hinay, A. A., Chen, L., Kuramochi, J., Sadamasu, K., Yoshimura, K., Asakura, H., Nagashima, M., The Genotype to Phenotype Japan (G2P-Japan) Consortium, , Ito, J., Sato, K.
10.1101/2023.11.14.566985 — Posted: 2023-11-15
SARS-CoV-2 nsp15 endoribonuclease antagonizes dsRNA-induced antiviral signaling
Otter, C. J., Bracci, N., Parenti, N. A., Ye, C., Li Hui, T., Asthana, A., Pfannenstiel, J. J., Jackson, N., Fehr, A. R., Silverman, R. H., Cohen, N. A., Martinez-Sobrido, L., Weiss, S. R.
10.1101/2023.11.15.566945 — Posted: 2023-11-15
Cost-effective boosting allocations in the post-Omicron era of COVID-19 management
Le, T. P., Conway, E., Akpan, E., Abell, I., Abraham, P., Baker, C. M., Campbell, P. T., Cromer, D., Lydeamore, M. J., McDonough, Y., Mueller, I., Ryan, G., Walker, C., Wang, Y., Carvalho, N., McVernon, J.
10.1101/2023.11.14.23298536 — Posted: 2023-11-15
Full-spike deep mutational scanning helps predict the evolutionary success of SARS-CoV-2 clades
Dadonaite, B., Brown, J., McMahon, T. E., Farrell, A. G., Asarnow, D., Stewart, C., Logue, J., Murrell, B., Chu, H. Y., Veesler, D., Bloom, J. D.
10.1101/2023.11.13.566961 — Posted: 2023-11-14
SARS-CoV-2 and its ORF3a, E and M viroporins activate inflammasome in human macrophages and induce of IL-1α in pulmonary epithelial and endothelial cells
Abrozek-Latecka, M., Kozlowski, P., Hoser, G., Bandyszewska, M., Hanusek, K., Nowis, D., Golab, J., Grzanka, M., Piekielko-Witkowska, A., Schulz, L., Hornung, F., Deinhardt-Emmer, S., Kozlowska, E., Skirecki, T.
10.1101/2023.11.13.566917 — Posted: 2023-11-14
cellstruct: Metrics scores to quantify the biological preservation between two embeddings
Loh, J. W., Ouyang, J. F.
10.1101/2023.11.13.566337 — Posted: 2023-11-14
Synthesis of Dendritic Cell-Targeted Polymeric Nanoparticles for Selective Delivery of mRNA Vaccines to Elicit Enhanced Immune Responses
Wong, C.-H.
10.1101/2023.11.13.566827 — Posted: 2023-11-14
Assessing the Impact of Mask Mandates on SARS-CoV-2 Transmission: A Case Study of Utah
Horn, A. C., Shoemaker, H. E., Keegan, L. T.
10.1101/2023.11.13.23298464 — Posted: 2023-11-13
A SOLUTION TO THE KERMACK AND MCKENDRICK INTEGRO-DIFFERENTIAL EQUATIONS WHICH ACCURATELY PROJECTS COVID-19 CASE DATA USING GOOGLE MOBILITY DATA AS AN INPUT
Duclos, T. G., Reichert, T.
10.1101/2023.11.13.23298463 — Posted: 2023-11-13
Integrating stimulus-organism-response model and theory of planned behavior to explore athletes intention to receive the COVID-19 vaccine booster - A moderated mediation model
Zhan, W., Deng, Q., Nguyen, V. B., Anh, T. P. D., Na, P. D., Shia, A.-S., Ku, G. C. M.
10.1101/2023.11.13.23298480 — Posted: 2023-11-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).